New US synthesis policy sets a staged procurement transition
A November 5 US policy sets phased screening requirements for nucleic-acid procurement by recipients and subrecipients of federal funding, with NIH confirming that existing requirements remain in force during the transition.
A November 5 White House policy requires recipients and subrecipients of federal funding to procure relevant synthetic nucleic acids and benchtop synthesis equipment from suppliers adhering to the government’s screening framework.
The procurement condition covers those recipients’ relevant purchases, including orders paid for from other funds. It links federal research funding to supplier verification, customer screening and review of orders. Research organizations therefore need to prepare procurement processes across the covered entity as the requirements take effect. [1]
The policy sets successive milestones: NIST standards within 90 days, an initial HHS supplier list within 160 days, the nucleic-acid procurement requirement at 250 days and the benchtop-synthesis requirement at 340 days. These are intervals from the memorandum, not separately verified calendar deadlines or evidence that the implementing work has been completed. [1]
NIH’s November 6 notice confirms that the existing 2024 screening requirements continue until the new policy is fully implemented. Research administrators can use the transition to identify affected purchases, review supplier documentation and follow the implementing guidance as it appears. The notice does not establish that any particular supplier is already approved under the future list. [2]
Sources & details 2 sources
Discuss in your voice app
Take the reporting, visual explanations and original sources into a conversation. Copy the brief, paste it into your preferred assistant, then start its voice mode.
Paste the brief into your voice app to discuss this reporting.Reporting sources
- National nucleic-acid synthesis screening policy
November 5 memorandum; scope applies to recipients/subrecipients and all relevant procurement, not only federally paid orders. Scope section printed p1/PDF p4 and Customers section printed p7/PDF p10; 90/160/250/340-day implementation milestones.
- NIH implementation notice
November 6 notice confirms the new policy and continuation of existing 2024 requirements during transition; distinct implementing agency, not an outcome evaluation.
Images & figures
The policy phases in requirements for relevant purchases by federal-funding recipients and subrecipients, including orders paid from other funds; existing rules continue during transition.
Euangelion · Source · Usage terms · Download figure